Cargando…

Late Complications in acute Leukemia patients following HSCT: A single center experience

Background: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for acute leukemia. As HSCT improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following HSCT. Subjects and Methods: The study includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaezi, Mohammad, Gharib, Cyrous, Souri, Maryam, Ghavamzadeh, Ardeshir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818783/
https://www.ncbi.nlm.nih.gov/pubmed/27047644
_version_ 1782425078341828608
author Vaezi, Mohammad
Gharib, Cyrous
Souri, Maryam
Ghavamzadeh, Ardeshir
author_facet Vaezi, Mohammad
Gharib, Cyrous
Souri, Maryam
Ghavamzadeh, Ardeshir
author_sort Vaezi, Mohammad
collection PubMed
description Background: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for acute leukemia. As HSCT improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following HSCT. Subjects and Methods: The study included 122 patients (65 male, 57 female) with leukemia (72 AML and 50 ALL) who received transplants from fully- matched siblings, unrelated donors and unrelated cord blood donors between February 2013 and August 2014 in Shariati Hospital. All study participants were over 18 years of age and had the minimum and maximum survival of 2 and 5 years, respectively. Patients who received HLA-haploidentical SCT were excluded from the study. All allogeneic recipients received busulfan and cyclophosphamide as conditioning regimen. Nobody received TBI-based conditioning regimen in this study. Patients were evaluated for cardiovascular, vision, psychological, endocrine, fertility problems and secondary malignancies one year after transplantation. Results : Data were analyzed using SPSS 15.0. Mitral and tricuspid regurgitation (TR/MR) were the most common cardiac complications (n=12, 10.5%).Thirty-nine percent of patients had psychological problems, especially depression (34%). Cataract was observed in 13% of patients and 34% complained of dry eye. Symptomatic pulmonary changes were found in 13 patients (10.6%). None of the HSCT survivors had experienced fertility before study entry. According to LH and FSH levels, 15% and 9% of females had ovarian failure, respectively. Testosterone level was less than normal in 49(84%) men and, according to their FSH and LH level, 20 (41%) had secondary hypogonadism and 29 (59%) had primary gonadal dysfunction. Conclusion: The results showed that patients who received Bu/Cy conditioning regimen experienced fewer late side effects such as cataract formation and hypothyroidism, compared to previous studies using TBI-based conditioning regimen.
format Online
Article
Text
id pubmed-4818783
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
record_format MEDLINE/PubMed
spelling pubmed-48187832016-04-04 Late Complications in acute Leukemia patients following HSCT: A single center experience Vaezi, Mohammad Gharib, Cyrous Souri, Maryam Ghavamzadeh, Ardeshir Int J Hematol Oncol Stem Cell Res Original Article Background: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for acute leukemia. As HSCT improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following HSCT. Subjects and Methods: The study included 122 patients (65 male, 57 female) with leukemia (72 AML and 50 ALL) who received transplants from fully- matched siblings, unrelated donors and unrelated cord blood donors between February 2013 and August 2014 in Shariati Hospital. All study participants were over 18 years of age and had the minimum and maximum survival of 2 and 5 years, respectively. Patients who received HLA-haploidentical SCT were excluded from the study. All allogeneic recipients received busulfan and cyclophosphamide as conditioning regimen. Nobody received TBI-based conditioning regimen in this study. Patients were evaluated for cardiovascular, vision, psychological, endocrine, fertility problems and secondary malignancies one year after transplantation. Results : Data were analyzed using SPSS 15.0. Mitral and tricuspid regurgitation (TR/MR) were the most common cardiac complications (n=12, 10.5%).Thirty-nine percent of patients had psychological problems, especially depression (34%). Cataract was observed in 13% of patients and 34% complained of dry eye. Symptomatic pulmonary changes were found in 13 patients (10.6%). None of the HSCT survivors had experienced fertility before study entry. According to LH and FSH levels, 15% and 9% of females had ovarian failure, respectively. Testosterone level was less than normal in 49(84%) men and, according to their FSH and LH level, 20 (41%) had secondary hypogonadism and 29 (59%) had primary gonadal dysfunction. Conclusion: The results showed that patients who received Bu/Cy conditioning regimen experienced fewer late side effects such as cataract formation and hypothyroidism, compared to previous studies using TBI-based conditioning regimen. Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2016-01-01 /pmc/articles/PMC4818783/ /pubmed/27047644 Text en Copyright : © International Journal of Hematology-Oncology and Stem Cell Research & Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vaezi, Mohammad
Gharib, Cyrous
Souri, Maryam
Ghavamzadeh, Ardeshir
Late Complications in acute Leukemia patients following HSCT: A single center experience
title Late Complications in acute Leukemia patients following HSCT: A single center experience
title_full Late Complications in acute Leukemia patients following HSCT: A single center experience
title_fullStr Late Complications in acute Leukemia patients following HSCT: A single center experience
title_full_unstemmed Late Complications in acute Leukemia patients following HSCT: A single center experience
title_short Late Complications in acute Leukemia patients following HSCT: A single center experience
title_sort late complications in acute leukemia patients following hsct: a single center experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818783/
https://www.ncbi.nlm.nih.gov/pubmed/27047644
work_keys_str_mv AT vaezimohammad latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience
AT gharibcyrous latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience
AT sourimaryam latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience
AT ghavamzadehardeshir latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience